AKR mice show a high incidence of spontaneous lymphomas that are virtually all of the T lymphocyte type and arise predominantly in the thymus (1). Thymus removal at the age of 1-3 mo markedly reduces the spontaneous tumor incidence. These thymectomized mice develop a low incidence of extrathymic lymphoid tumors, which appear late in life. Some lymphomas occurring sporadically in peripheral lymphoid tissues of old intact or thymectomized mice were shown to have a dual nature, bearing characteristics of both T and B cells (2, 3). Although the thymus has been considered as the primary site of neoplastic transformation and proliferation, we have shown previously (4) that premalignant lymphoid cells (PLC) were present in fetal liver of 16-d-old AKR embryos, and among bone marrow (BM) cells of intact AKR mice from the age of 14 d onwards. Thus, using the transplantation bioassay method, we showed (4) that bone marrow cells from AKR mice of different ages, when transferred into intact irradiated (AKR × DBA/2)F1 recipients, caused T cell lymphoma development of AKR origin in 80-100% of the recipients. In contrast, transplantation tests failed to reveal the presence of PLC in the thymus or spleen during the first few months of life (5, 6). These findings suggest that the thymus provides a suitable environment for the proliferation and differentiation of PLC present in BM since birth. PLC present in intact mice have been shown to differ qualitatively from leukemic cells. They have the characteristics of prothymocytes, and require the thymus microenvironment for further proliferation into autonomous leukemic cells (7). Since we suggest that the initial site of PLC occurrence is among bone marrow cells, they should be present irrespective of presence or absence of the thymus.
Materials and Methods
Mice. AKR/J and (AKR/J x DBA/2)F~ mice were obtained from the breeding center at The Weizmann Institute of Science, and from The Jackson Laboratory (Bar Harbor, ME).
Monoclonal Antibodies and Antisera. Mouse anti-mouse Thy-l.1 (HO-22-1) IgM, anti-I-A k (10-2-16), rat anti-mouse Lyt-1 (53-7.3), and anti-Lyt-2 (53-6.7) were obtained from Salk Institute Distribution, San Diego, CA. Mouse anti-mouse MCF (18-5) IgG2b was a gift from J. Portis, Rocky Mountain Laboratories, MT (8) . Rat anti-RA3-6B2 and anti-RA3-2C2 were obtained from R. Coffman (DNAX, Research Institute of Molecular and Cellular Biology Inc., Palo Alto, CA) (9) . Rat anti-mouse Fc receptor (FcR) (IgG1) NEI-032 was purchased from New England Nuclear, Boston, MA. Goat anti-mouse # chain (anti-38-C-13 IgM) F(ab)2 was a gift from J. Haimovich, Tel Aviv University, Tel Aviv, Israel. Rabbit anti-b chain was obtained from I. Zan-Bar, The Weizmann Institute of Science. Goat anti-IgM (heavy and light chains) was purchased from Bio-Yeda, Rehovot, Israel. Anti-TL.4 was prepared in our laboratory, as previously described (6) . The fluorescein isothiocyanate (FITC) conjugates of anti-mouse IgG (Meloy Laboratories, Inc., Springfield, VA), anti-rat IgG, anti-goat IgG, anti-rabbit IgG (Bio-Yeda), and antimouse Ig (Nordic, Tilburg, The Netherlands) were used for fluorescence labeling.
lmraunofluorescence and Flow Cytometry (FCM) . Immunofluorescence was performed as described in detail elsewhere (6) . Fluorescence was measured by FCM analysis, using FACS II (Becton-Dickinson Immunocytochemistry Systems, Mountain View, CA).
Results

Identification of PLC Among BM Cells.
The leukemogenic potential of BM cells from thymectomized (when 40-60 d old) AKR mice, removed at age 250-360 d, was tested. BM cells were transplanted into intact or thymectomized, irradiated (400 rad whole-body irradiation) or nonirradiated 6-wk-old AKR or (AKR X DBA/2)F1 mice (presence of thymus and irradiation of the recipient are prerequisites for the development of PLC derived from 14-d-old AKR mice into T cell lymphoma [7] ). Hybrid mice were used as recipients to verify the AKR origin of the developing tumors (by serological or transplantation tests). The results obtained, summarized in Table I , clearly indicate that each thymectomized AKR mouse was a carrier of PLC, since we obtained a 100% lymphoma incidence of AKR origin after BM transplantation. The absence of thymus in the recipients and lack of radiation pretreatment did not affect the high incidence of lymphoma development in the BM recipients. All the lymphomas developed extrathymically, predominantly in the spleen, and in many cases, also involved lymph node and liver dissemination.
Characteristics of Tumors. The cell surface phenotypes of these obtained lymphoid tumors were examined by flow microfluorometry performed on a Becton-Dickinson FACS II. All the 25 lymphomas obtained were found to be Thy-!-, but were positively stained with anti IgM. 12 out of these 25 lymphomas were analyzed more extensively with antibodies that could indicate the T or B cell attributes of these lymphoid tumors: anti-Thy-1, anti-u, anti-& RA3-2C2 (which reacts with pre-B and B cells, and weakly with peripheral T cells [9] ), RA3-6B2 (reacts only with B cells [9] ), anti-I-A k, and anti-FcR. We also tested the possible expression of the thymus leukemia alloantigen, TL.4, on the cell surface of these lymphomas, because we had previously found (6) its expression on BM cells of 1-15-d-old AKR mice. Since anti-Lyt-1 was shown to mark a subpopulation of B cells at several different stages of differentiation (10), as well as B cell lymphomas (11), we included it in testing the lymphomas, mAb 18-5, which reacts with the envelope recombinant virus, MCF, (8) (considered to have a major role in T cell leukemia development in AKR mice) was also included in the analysis to obtain preliminary evidence of the possible involvement of the AKR recombinant virus in the development of these tumors. The results of these immunofluorescence studies are summarized in Table II , and representative fluorescence profiles are shown in Fig. 1 . All tumors were Thy-l-, and stained with antibodies specific for B cells. The expression of Lyt-I on these B cell lymphomas coincides with similar observations by other investigators (11, 12) . The most surprising observation was the expression of TL.4 on all tested tumors. To ascertain that the surface markers of these lymphomas were integral membrane components of known molecular weight, the following tests were performed: lactoperoxidase iodination (13) to scan for cell surface markers, and metabolic labeling with [35S]methionine for the biosynthesis of the relevant markers. A comparative analysis of a T and B cell lymphoma derived from AKR mice was done. The lysates from the tumors were immunoprecipitated with different antibodies and run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with suitable markers (14) . u heavy chain (~68,000 tool wt) was immunoprecipitated from the B cell lymphoma (24-180), and a surface glycoprotein of 220,000 mol wt was immunoprecipitated with mAb RA3-2C2, in The involvement of MCF in the development of the B cell neoplasms tested is doubtful, since cells stained with 18-5 were observed only in three out of eight tumors tested (Table II) . The possible contribution of ecotropic murine leukemia virus (MuLV) to B cell lymphoma development has been suggested in recent studies by Fredrickson et al. (16) . The inbred Swiss strain, NFS, which lacks the genetic information for ecotropic MuLV develops a low incidence of nonthymic lymphomas at the age of 12-18 mo. Insertion of AKR viral genes (Akv-1 and Akv-2) on NFS background (resulting in NFS-V congenic mice for ecotropic MuLV induction loci) rendered them more susceptible (23.8% lymphomas in NFS-V congenic mice vs. 7% in NFS mice) to the development of nonthymic iymphomas of B cell phenotype (16) . Summary AKR mice, 6-12 mo after birth, display a high incidence of spontaneous T cell lymphomas that can be prevented by thymus removal at the age of 1-3 mo. We report here the presence of dormant preleukemic cells among bone marrow cells of 8-12-too-old AKR mice that have been thymectomized when 40-60 d old. Transplantation of bone marrow cells from these thymectomized AKR donors into syngeneic or hybrid (AKR X DBA/2)F1 intact or thymectomized recipients resulted in lymphoma development of AKR origin in 80-100% of the recipients. Analysis, by flow microfluorometry, of the antigenic cell surface phenotypes of the developing lymphomas revealed that all tumors were B cell lymphomas, since the cells stained with class-specific anti-IgM reagents and other reagents specific for B cells (RA3-2C2, RA3-6B2, anti-I-A, and anti-Fc receptor), and were Thy-1-. All these B cell tumors also expressed two T cell differentiation antigens, TL.4, found exclusively on T cell lymphomas, and Lyt-1 antigen, previously shown (11) to be expressed on some B cell neoplasms. The surface markers ~, I-A, RA3-2C2, and TL.4 identified by immunofluorescence, were shown to be integral membrane components synthesized by the tumor cells, rather than passively acquired proteins.
